本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Monte Rosa Therapeutics

14.36
+0.58504.25%
成交量:61.52萬
成交額:887.89萬
市值:12.25億
市盈率:-8.23
高:14.84
開:14.06
低:14.00
收:13.78
52周最高:25.77
52周最低:4.54
股本:8,531.34萬
流通股本:5,447.61萬
量比:0.56
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-1.7450
每股收益(LYR):-0.4650
淨資產收益率:-42.66%
總資產收益率:-21.63%
市淨率:2.51
市盈率(LYR):-30.88

資料載入中...

2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/22

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities